Covalon leverages its patented medical technology platforms and expertise in two ways; (i) we develop products that we sell under Covalon's name; and (ii) we develop and commercialize medical products for other medical companies under development and license contracts. The Majority of Covalon-branded products are sold through independent distributors to various health care providers such as hospitals, wound care centers, burn centres, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians' offices. Our products require regulatory clearances and are sold on prescription basis in the United States, Canada, and a number of international countries. Covalon currently has three proprietary platform technologies that have the potential to be developed into dozens of medical devices: (i) Collagen matrix; (ii) Antimicrobial silicone adhesive; and (iii) Medical coating technology. These platform technologies are protected by patents, patent applications and patents pending, patented and proprietary manufacturing processes, trade secrets, brands, trademarks, and trade names.